Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 16, 2022; 10(8): 2382-2392
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2382
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2382
Baseline characteristics | The control group | The pulmonary infection group | χ2 | P value |
Cases, n | 96 | 85 | ||
Gender (male/female) | 59/37 | 50/35 | 0.131 | 0.718 |
Age range (yr) | 67.44 ± 8.51 | 68.83 ± 8.90 | 1.073 | 0.285 |
Course of disease (yr) | 16.35 ± 7.68 | 17.13 ± 8.06 | 0.666 | 0.506 |
Smoking history, n (%) | 68 (70.83) | 65 (76.47) | 0.735 | 0.391 |
FEV1 (%) | 47.65 ± 10.07 | 41.30 ± 9.91 | 4.266 | < 0.001 |
FEV1/FVC (%) | 58.24 ± 8.62 | 50.48 ± 9.13 | 5.879 | < 0.001 |
- Citation: Fei ZY, Wang J, Liang J, Zhou X, Guo M. Analysis of bacterial spectrum, activin A, and CD64 in chronic obstructive pulmonary disease patients complicated with pulmonary infections. World J Clin Cases 2022; 10(8): 2382-2392
- URL: https://www.wjgnet.com/2307-8960/full/v10/i8/2382.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i8.2382